Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ACLY antibody

This anti-ACLY antibody is a Mouse Monoclonal antibody detecting ACLY in WB, ELISA, IHC, FACS and IC. Suitable for Human.
Catalog No. ABIN2206320

Quick Overview for ACLY antibody (ABIN2206320)

Target

See all ACLY Antibodies
ACLY (ATP Citrate Lyase (ACLY))

Reactivity

  • 96
  • 35
  • 33
  • 9
  • 6
  • 6
  • 5
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 86
  • 13
Mouse

Clonality

  • 72
  • 27
Monoclonal

Conjugate

  • 53
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This ACLY antibody is un-conjugated

Application

  • 81
  • 36
  • 27
  • 26
  • 19
  • 19
  • 17
  • 12
  • 11
  • 6
  • 6
  • 3
  • 2
  • 2
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunochromatography (IC)

Clone

13B53
  • Cross-Reactivity

    Human, Monkey, Mouse (Murine)

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu Mk Mo

    Characteristics

    ATP-Citrate Lyase (ACLY, ATP Citrate (pro-S) Lyase, ATP Citrate Synthase, Citrate Cleavage Enzyme, CLATP, EC 2.3.3.8)

    Purification

    Purified

    Immunogen

    Purified recombinant fragment of human ACLY (AA: 306-502 ) expressed in E. coli.

    Isotype

    IgG1
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified antibody in PBS with 0.05 % sodium azide and 0.5 % protein stabilizer

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    ACLY (ATP Citrate Lyase (ACLY))

    Alternative Name

    ATP-Citrate Lyase

    UniProt

    P53396

    Pathways

    Warburg Effect
You are here:
Chat with us!